This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.

Cardiogen

Cardiogen is a short peptide with known properties as a bioregulator. Research shows that its primary effects are on fibroblasts, the cells responsible for tissue repair and scar formation throughout the body. Though the focus on cardiogen has been on its role in a variety of cardiovascular diseases (hence the name), research shows that its ability to alter fibroblast activity has potential benefits in a variety of tissues. In addition, cardiogen appears to by a synergistic peptide, enhancing the benefit of certain standard therapies and thereby improving long-term outcomes while reducing side effects. Finally, preliminary research in rat models suggests that cardiogen may increase rates of apoptosis in tumor cells.

Cardiogen Structure

Molecular Formula: C18H31N7O9 Molecular Weight: 489.5 g/mol PubChem CID: 11583989 Alternative Names: SCHEMBL319451

Cardiogen and the Heart

In the heart, cardiogen appears to stimulate cardiomyocyte proliferation while reducing fibroblast growth and development. This leads to decreased scar formation and improved long-term outcomes in regards to cardiac remodeling leading to heart failure. Additionally, it appears that cardiogen 20mg can decrease p53 protein expression and thereby diminish rates of apoptosis.

Cardiogen and Cancer

Even though cardiogen reduces apoptosis in heart cells by down-regulating p53 expression, it may have the opposite effect in tumor cells. Research in rat models of M-1 sarcoma shows that apoptosis levels are higher in the tumor cells following cardiogen administration. What is more, the effect is does-dependent, indicating that the biological effect is real. The peptide appears to enhance apoptosis in tumor cells and may be somewhat selective for tumor cells due to their enhanced and unusual vascular supply. This may make cardiogen a targeted treatment for at least some types of cancer. In addition, if the peptide enhances the action of standard cancer treatments (as it does in heart disease treatment), then it may prove a very potent addition to the arsenal of cancer fighters.

Doctors Levdik and Knyazkin, both of whom have worked in some capacity with Vladimir Khavinson through the St. Petersburg Institute of Bioregulation and Gerontology and the Russian Academy of Medical Sciences, have extensive experience researching the impact of amino acids and short peptides on both cancer and healthy tissues as they become dysfunctional and precancerous. Their work with Cardiogen 20mg has positioned it as the next possible candidate for approval, in Russia, for the treatment of sarcoma.

Cardiogen 20mg and the Prostate

Research in tissue cultures shows that cardiogen, along with several similar peptides, alters the expression of signaling factors in fibroblasts of the prostate. Levels of these signaling factors are important in establishing favorable a microenvironment within tumors and may contribute to both the development and progression of prostate cancer. Solid evidence shows that the synthesis of these markers is substantially altered in aging and senescent fibroblasts, which may explain why prostate cancer is almost ubiquitous in older men but nearly unheard of in younger men[3]. In fact, studies show that cardiogen can normalize levels of these signaling molecules to match or even improve upon what is seen in young cell cultures, suggesting that cardiogen may be effective both in preventing prostate cancer and in controlling its progression once it develops.

Cardiogen Summary

Cardiogen 20mg, while less researched than some other bioregulators, appears to have potent effects on multiple body tissues including the heart and prostate. Additionally, the peptide may be beneficial in the treatment of certain types of cancer, particularly sarcoma. Currently, the biggest benefits of cardiogen appear to be in the settings of heart attack, hypertension, and chronic heart failure where the peptide not only offers benefits of its own accord, but acts in a synergistic manner with established treatments.

Cardiogen exhibits minimal side effects, good oral and excellent subcutaneous bioavailability in mice. Per kg dosage in mice does not scale to humans. Cardiogen for sale at  peptide Review hub is limited to educational and scientific research only, not for human consumption. Only buy Cardiogen if you are a licensed researcher.

Scientific Journal Author

Vladimir Khavinson is a Professor, President of the European region of the International Association of Gerontology and Geriatrics; Member of the Russian and Ukrainian Academies of Medical Sciences; Main gerontologist of the Health Committee of the Government of Saint Petersburg, Russia; Director of the Saint Petersburg Institute of Bioregulation and Gerontology; Vice-president of Gerontological Society of the Russian Academy of Sciences; Head of the Chair of Gerontology and Geriatrics of the North-Western State Medical University, St-Petersburg; Colonel of medical service (USSR, Russia), retired. Vladimir Khavinson is known for the discovery, experimental and clinical studies of new classes of peptide bioregulators as well as for the development of bioregulating peptide therapy. He is engaged in studying of the role of peptides in regulation of the mechanisms of ageing. His main field of actions is design, pre-clinical and clinical studies of new peptide geroprotectors. A 40-year-long investigation resulted in a multitude of methods of application of peptide bioregulators to slow down the process of ageing and increase human life span. Six peptide-based pharmaceuticals and 64 peptide food supplements have been introduced into clinical practice by V. Khavinson. He is an author of 196 patents (Russian and international) as well as of 775 scientific publications. His major achievements are presented in two books: “Peptides and Ageing” (NEL, 2002) and “Gerontological aspects of genome peptide regulation” (Karger AG, 2005). Vladimir Khavinson introduced scientific specialty "Gerontology and Geriatrics" in the Russian Federation on the governmental level. Academic Council headed by V. Khavinson has oversighted over 200 Ph.D. and Doctorate theses from many different countries.

Prof. Vladimir Khavinson is being referenced as one of the leading scientists involved in the research and development of Cardiogen. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between                         peptide Review hub and this doctor. The purpose of citing the doctor is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying this peptide.

Chonluten (EDG), also known as Tripeptide T-34, is a short bioregulatory peptide that has gained attention in respiratory biology, gerontology, gene-regulation research, and inflammation studies. Researchers have investigated Chonluten for its apparent ability to influence gene expression, regulate antioxidant pathways, modulate inflammatory responses, and support tissue-specific function in the lungs and gastrointestinal tract.

As interest in bioregulatory peptides continues to expand, researchers frequently compare Chonluten vendors based on purity, analytical testing, pricing, supplier transparency, and overall product quality.

This Chonluten Vendor Price Comparison Guide helps researchers evaluate suppliers using objective criteria including:

• Product Pricing

• Cost Per Milligram

• Product Purity

• Third-Party Testing

• Certificate of Analysis (COA)

• Vendor Reputation

• Customer Reviews

• Shipping Performance

• Product Availability

• Overall Value

Whether you're searching for the lowest-priced Chonluten supplier, vendors with extensive laboratory testing, or peptide companies known for consistency and transparency, this guide provides a framework for comparison.

Explore Chonluten Vendors by Criteria

Most Popular Chonluten Vendors

Compare suppliers frequently selected by researchers studying respiratory biology, geroprotection, and peptide bioregulators.

Highest Reviewed Chonluten Vendors

Discover vendors with strong customer satisfaction and positive industry reputations.

Lowest Price Chonluten Vendors

Identify suppliers offering competitive pricing and attractive cost-per-milligram value.

Highest Purity Chonluten Vendors

Review suppliers providing transparent purity verification and analytical testing.

Best Value Chonluten Vendors

Compare testing standards, product quality, customer service, and pricing to determine overall value.

Fastest Shipping Chonluten Vendors

Evaluate order-fulfillment speed, shipping reliability, and packaging quality.

Newly Listed Chonluten Vendors

Explore recently added suppliers offering Chonluten research products.

What Is Chonluten?

Overview

Chonluten is a synthetic tripeptide bioregulator studied primarily for its potential effects on:

• Gene expression

• Pulmonary tissue regulation

• Antioxidant pathways

• Inflammatory signaling

• Cellular aging

• Mucosal health

• Gastrointestinal tissue regulation

Researchers classify Chonluten among the Khavinson bioregulatory peptides due to its role in cellular and genomic regulation studies.

Its apparent tissue-specific activity in lung tissue has made it a significant area of investigation in respiratory research.

Molecular Characteristics

Peptide Information

Researchers evaluating Chonluten products should review all molecular specifications and analytical documentation.

Peptide Name

Chonluten

Alternative Names

• T-34 Tripeptide

• EDG

• Tripeptide T-34

Molecular Formula

C11H17N3O8

Molecular Weight

319.27 g/mol

PubChem CID

194641

CAS Number

75007-24-8

Classification

Bioregulatory Tripeptide

Research Category

Respiratory & Geroprotection Research

Why Researchers Compare Chonluten Vendors

Research quality depends heavily on peptide quality, testing standards, and manufacturing consistency.

Differences among suppliers may include:

• Purity levels

• Batch consistency

• Manufacturing quality

• Stability testing

• Product handling

• Product documentation

• Shipping conditions

• Quality-control systems

Careful vendor evaluation helps improve research reproducibility and consistency.

How We Compare Chonluten Vendors

Third-Party Laboratory Testing

Independent laboratory verification remains one of the strongest indicators of peptide quality.

Researchers should prioritize suppliers providing:

• Third-party testing

• Identity verification

• Purity analysis

• Batch-specific reports

Certificate of Analysis (COA)

A quality COA should include:

• Batch number

• Testing date

• Purity results

• Identity verification

• Testing methodologies

Product Purity

Purity remains one of the most important factors when sourcing research peptides.

Suppliers offering transparent purity reporting generally rank higher in quality evaluations.

Cost Per Milligram

Product pricing alone does not provide a complete picture of value.

Cost Per Milligram Formula

Product Price ÷ Total Milligrams = Cost Per Milligram

This allows researchers to compare suppliers more effectively.

Customer Reviews

Customer experiences may provide insight regarding:

• Product consistency

• Packaging quality

• Shipping reliability

• Customer support

• Purchasing experience

Vendor Reputation

Established peptide suppliers often demonstrate:

• Reliable quality-control procedures

• Strong testing programs

• Positive customer feedback

• Consistent inventory availability

Current Research & Evidence

Gene Regulation Research

One of the most significant areas of Chonluten research involves gene-expression regulation.

Researchers continue investigating how short peptides may interact with:

• DNA regulatory regions

• Transcription factors

• Epigenetic mechanisms

• Cellular signaling pathways

This research forms the basis of Chonluten's classification as a bioregulatory peptide.

Bioregulation Research

Studies involving short peptides suggest they may influence:

• Cellular differentiation

• Cellular survival

• Cellular repair mechanisms

• Tissue-specific regulation

Researchers continue evaluating these mechanisms in laboratory models.

Geroprotection Research

Chonluten has gained attention in aging and longevity research.

Scientists investigate its potential role in:

• Cellular maintenance

• Age-associated functional decline

• Oxidative stress regulation

• Tissue preservation

This has placed Chonluten among the more studied peptides in gerontology-focused peptide research.

Key Findings on Chonluten Research

Respiratory System Research

Chonluten is best known for its apparent tissue-specific relationship with pulmonary tissues.

Researchers continue studying pathways involving:

• Bronchial mucosal function

• Pulmonary inflammation

• Respiratory epithelial health

• Lung-tissue maintenance

These investigations make respiratory biology one of the largest areas of Chonluten research.

Antioxidant Pathway Research

Research suggests Chonluten may influence genes associated with antioxidant defense systems.

Scientists continue investigating relationships involving:

• Oxidative stress

• Cellular defense mechanisms

• Antioxidant enzyme pathways

• Tissue resilience

Inflammatory Signaling Research

Experimental studies have examined interactions between Chonluten and pathways involving:

• TNF-alpha signaling

• COX-2 activity

• Stress-response pathways

• Cellular inflammatory responses

Researchers continue exploring these mechanisms.

Stress Response Research

Research has identified potential interactions involving genes related to:

• Heat-shock proteins

• Cellular adaptation

• Environmental stress responses

• Tissue-protective pathways

This remains an active area of investigation.

Gastrointestinal Research

Although most Chonluten studies focus on respiratory tissues, researchers have also explored potential relationships with:

• Gastrointestinal mucosal function

• Digestive-tract inflammation

• Tissue repair mechanisms

• GI barrier integrity

Further investigation remains ongoing.

Chonluten & Aging Research

Researchers continue studying Chonluten because of growing evidence that short bioregulatory peptides may influence age-related cellular decline.

Areas under investigation include:

• Cellular longevity

• Oxidative damage reduction

• Gene-expression regulation

• Tissue-maintenance pathways

• Healthy aging processes

This remains one of the most promising areas of Chonluten research.

Research Limitations

Most findings involving Chonluten originate from:

• Laboratory studies

• Cell-culture experiments

• Animal investigations

• Early-stage bioregulation research

Additional research remains necessary to fully characterize the peptide's mechanisms and long-term biological effects.

Research findings should not be interpreted as evidence of approved therapeutic applications.

Product Quality & Analytical Testing

Why Testing Matters

Research-grade Chonluten products should undergo testing to verify:

• Identity

• Purity

• Stability

• Potency

• Batch consistency

Common Testing Methods

High-Performance Liquid Chromatography (HPLC)

Used to assess peptide purity and detect impurities.

Mass Spectrometry (MS)

Used to verify molecular identity and composition.

Identity Verification Testing

Confirms peptide authenticity.

Stability Testing

Evaluates peptide integrity during storage.

Batch Consistency Testing

Measures reproducibility across manufacturing lots.

Understanding Chonluten Pricing

Several factors influence Chonluten pricing among suppliers.

Product Purity

Higher-purity preparations often command premium pricing.

Testing Standards

Comprehensive laboratory verification increases transparency and quality assurance.

Manufacturing Quality

Strict quality-control procedures may increase production costs.

Market Availability

Specialized bioregulatory peptides are often produced in smaller quantities than mainstream peptides.

Vendor Reputation

Trusted suppliers often charge more due to established quality-assurance practices.

Chonluten Vendor Evaluation Checklist

Quality Verification

✅ Third-party testing available

✅ Certificate of Analysis provided

✅ Identity verification documented

✅ Purity information disclosed

✅ Batch-specific testing available

Vendor Reliability

✅ Positive customer reviews

✅ Transparent company information

✅ Responsive customer support

✅ Reliable inventory availability

Purchasing Experience

✅ Secure checkout process

✅ Shipment tracking available

✅ Clear refund policies

✅ Reliable fulfillment performance

Red Flags When Comparing Vendors

Testing Concerns

❌ No third-party testing

❌ Missing Certificates of Analysis

❌ Unverified purity claims

❌ Outdated laboratory reports

Transparency Issues

❌ Hidden product specifications

❌ Missing batch information

❌ Limited documentation

❌ No company contact information

Service Problems

❌ Frequent stock shortages

❌ Poor communication

❌ Negative customer reviews

❌ Unclear shipping policies

How to Choose the Best Chonluten Vendor

Prioritize Laboratory Testing

Choose vendors providing third-party testing and batch-specific COAs.

Compare Overall Value

Evaluate purity, testing standards, customer service, and pricing together.

Review Documentation

Verify analytical reports before purchasing.

Evaluate Vendor Reputation

Established peptide suppliers often provide greater consistency and stronger quality assurance.

Match Products to Research Needs

Select suppliers whose quality standards align with your laboratory requirements.

Frequently Asked Questions

What is Chonluten?

Chonluten (EDG) is a synthetic bioregulatory tripeptide studied primarily in respiratory biology, gene-regulation research, inflammation pathways, and aging science.

What is Chonluten used for in research?

Researchers investigate Chonluten in studies involving pulmonary tissue regulation, antioxidant pathways, inflammatory signaling, mucosal biology, and geroprotection.

Why compare Chonluten vendors?

Purity, analytical testing, documentation quality, pricing, and supplier reliability can vary considerably between vendors.

What should researchers review before purchasing?

Researchers should evaluate:

• Certificate of Analysis

• Purity testing

• Third-party verification

• Identity confirmation

• Vendor reputation

• Customer reviews

Why is third-party testing important?

Independent testing helps verify product identity, purity, and batch consistency while improving transparency.

Is the cheapest supplier always the best option?

No. Product quality, testing standards, and supplier reliability are often more important than price alone.

How often should vendor comparisons be updated?

Pricing, testing reports, inventory availability, and supplier policies can change frequently and should be reviewed regularly.

Final Thoughts

Chonluten is one of the more intriguing bioregulatory peptides under investigation because of its potential influence on gene-expression pathways, respiratory tissue regulation, antioxidant defenses, and aging-related cellular processes. Its apparent tissue-specific activity in the lungs and secondary activity in the gastrointestinal tract continue to drive scientific interest.

When comparing Chonluten vendors, researchers should prioritize purity verification, third-party laboratory testing, COA availability, supplier reputation, and overall value rather than focusing exclusively on price. Careful supplier evaluation helps ensure reliable, reproducible research outcomes.